Poland· PL-100522446
Verrumal
A brak product containing acidum salicylicum + fluorouracilum, registered in Poland by Allpharm Sp. z o.o. sp.k..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Acidum salicylicum + Fluorouracilum
- Manufacturer
- Allpharm Sp. z o.o. sp.k.
- Country
- Poland (PL)
- ATC code
- BRAK
- ATC class
- BRAK
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991582531
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Acidum salicylicum + fluorouracilum in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyActikerallAlmirall Hermal Gmbh
- CzechiaACTIKERALLAlmirall Hermal GmbH, Reinbek
- NorwayActikerallAlmirall Hermal GmbH
- SpainACTIKERALL 5 MG/G + 100 MG/G SOLUCION CUTANEAAlmirall Hermal Gmbh
- SwitzerlandActikerall
- SwedenActikerall 5 mg/g + 100 mg/g Kutan lösningAlmirall Hermal GmbH
- FinlandActikerallAlmirall Hermal GmbH
- United KingdomActikerall 5mg/g / 100mg/g cutaneous solutionAlmirall Ltd
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Actikerall, Verrumal
- Czechia · Actikerall, Verrumal
- Germany · Actikerall, Verrucutan
- Denmark · Actikerall
- Estonia · Actikerall
- Spain · Actikerall, Verrucutan
- Finland · Actikerall
- United Kingdom (Northern Ireland) · Actikerall
- Greece · Actiker, Verruca Hermal
- Croatia · Verrucutan
- Hungary · Verrumal
- Iceland · Actikerall
- Italy · Actikerall
- Luxembourg · Actikerall, Verrumal
- Latvia · Actikerall
- Norway · Actikerall
- Portugal · Actikerall, Verrucare
- Sweden · Actikerall
- Slovakia · Actikerall, Verrumal
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa15fa50-7fb3-4b63-9087-54e309d7525d GET /v1/drugs/aa15fa50-7fb3-4b63-9087-54e309d7525d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór na skórę",
"source": "urpl",
"strength": "100 mg/g + 5 mg/g",
"packaging": "05909991582531 ¦ Rp ¦ 163257\n1 butelka 13 ml",
"substance": "Acidum salicylicum 100 mg/g + Fluorouracilum 5 mg/g",
"common_name": "Acidum salicylicum + Fluorouracilum",
"pl_product_id": "100522446",
"pozwolenie_nr": "261/25",
"auth_procedure": "IR",
"authorisation_validity": "2030-08-08"
}See everything about acidum salicylicum + fluorouracilum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.